IRD

Opus Genetics
IRD

Upgrade to unlock
Buy
Hold
Sell

4 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$10.75
97% upside
High target

4 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Oppenheimer
Oppenheimer
Andreas Argyrides
100% 1-yr IRD win rate
16 Mar ‘26 1 month ago
Wedbush
Wedbush
Yun Zhong
100% 1-yr IRD win rate
12 Mar ‘26 1 month ago
Chardan Capital
Chardan Capital
Daniil Gataulin
75% 1-yr IRD win rate
12 Mar ‘26 1 month ago
BTIG
BTIG
Thomas Shrader
100% 1-yr IRD win rate
2 Mar ‘26 1 month ago